Crossmark

Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study

Crossref DOI link: https://doi.org/10.1016/j.opresp.2023.100232

Published Print: 2023-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Molina, Jesús http://orcid.org/0000-0002-4716-3152
Plaza, Vicente

Nuevo, Javier

Gutiérrez, Martín

Sicras-Mainar, Antoni

Valero, Antonio
Funding

Funding for this research was provided by:

AstraZeneca España
License Information

Text and Data Mining valid from 2023-04-01

Text and Data Mining valid from 2023-04-01

Version of Record valid from 2023-01-03
More Information

This article is maintained by: Elsevier

Article Title: Clinical Consequences of the Overuse of Short-Acting β2-Adrenergic Agonists (SABA) in the Treatment of Asthma in Spain: The SABINA Study

Journal Title: Open Respiratory Archives

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.opresp.2023.100232

Content Type: simple-article

Copyright: © 2023 Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Published by Elsevier España, S.L.U.